CSIMarket Company Name, Ticker, Suppliers, else..


Innate Pharma Sa  (NASDAQ: IPHA)
Other Ticker:  
 

Innate Pharma Sa

IPHA's Fundamental analysis



Looking into Innate Pharma Sa growth rates, revenue grew by 6.88 % in IV. Quarter 2023 from the same quarter a year ago. Ranking at No. 1368

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -1.86 %

Innate Pharma Sa net loss decreased from $-65 millions, to $-8 millions in IV. Quarter 2023,

• More on IPHA's Growth


Innate Pharma Sa
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 1.78 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2.43.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.17.


• More on IPHA's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 385,687
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 0.69

Innate Pharma Sa
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 1.78 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2.43.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.17.

Innate Pharma Sa Price to Book Ratio is at 2.89 lower than Industry Avg. of 18217.1. and higher than S&P 500 Avg. of 0.01

• More on IPHA's Valuation

•  Market Capitalization (Millions $) 168
•  Shares Outstanding (Millions) 84
•  Employees 179
•  Revenues (TTM) (Millions $) 69
•  Net Income (TTM) (Millions $) -8
•  Cash Flow (TTM) (Millions $) 94
•  Capital Exp. (TTM) (Millions $) 0
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 385,687
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 0.69

•  Market Capitalization (Millions $) 168
•  Shares Outstanding (Millions) 84
•  Employees 179
•  Revenues (TTM) (Millions $) 69
•  Net Income (TTM) (Millions $) -8
•  Cash Flow (TTM) (Millions $) 94
•  Capital Exp. (TTM) (Millions $) 0





  Ratio
•   Capital Ratio (MRQ) 3.73
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.95
•  Asset Turnover Ratio (TTM) 0.33
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com